Evamist was never likely to be the killer application. The male testosterone will be a much better earner. Still a great company with big future. Also has added advantage of being a PDF. Was lucky to buy in the 40's so am happy to hold for a while. ABM- Ambros gave them a good valuation. Although I don't think they are that swithced on. They were the underwriters for VCR. And have pushed a few other dogs over the years. But this coy has always looked the goods. Pay not far off now.
Add to My Watchlist
What is My Watchlist?